83-5967-51　［取扱停止］Lifastuzumab Vedotin (SLC34A2) 100ug　591970

特徴

• Lifastuzumab vedotin is under investigation in clinical trial NCT01363947 (safety and pharmacokinetics of escalating doses of DNIB0600A in participants with non-small cell lung cancer (NSCLC) and platinum resistant ovarian cancer).
• Applications:Suitable for use in ELISA and SDS-PAGE.
• Other applications not tested.
• Recommended Dilution:Optimal dilutions to be determined by the researcher.
• Storage and Stability:May be stored at 4℃ for short-term only.
• Aliquot to avoid repeated freezing and thawing.
• Store at -20℃.
• Aliquots are stable for 12 months after receipt.
• For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

仕様

• Size：100ug
• 抗体種類：Mab
• 宿主：human
• Grade：Highly Purified
• Purity：≥95%
• Form：Supplied as a liquid in PBS, pH 7.5.
• Specificity：Recognizes Lifastuzumab Vedotin (SLC34A2).
• Isotype：IgG1,k
• Calc Applications Abbrev：E
• Immunogen：Recombinant protein corresponding to humanized SLC34A2 [Homo sapiens], expressed in CHO cells.
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]